Our Investment Focus

We make venture and growth equity investments within lifescience, focusing on pharmaceuticals and biopharmaceuticals, medtech and diagnostics companies. We will primarily invest in clinical projects and companies and we are particularly interested in the speciality pharma segment. We will also invest in medtech and diagnostics companies as they are approaching commercialization. We are open to opportunities in all therapeutic areas.

We have an international reach. We will take the role of lead investor in northern Europe and will be active owners with direct support of, and communication with, management and representation on the supervisory board of companies invested in.

Our growth equity investments are made in growing and maturing life sciences companies seeking equity capital for expansion, acquisitions, buy-outs etc. These companies are likely to have revenues and operating earnings.